acetylcysteine has been researched along with Chorioamnionitis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelghany, O; Bahtiyar, MO; Bhandari, V; Buhimschi, CS; Buhimschi, IA; Dulay, AT; Lipkind, HS; Mieth, S; Razeq, SA; Rogers, L; Schneider, L; Zhao, G | 1 |
| Conde-Agudelo, A; Garcia Sánchez, ÁJ; Jung, EJ; Romero, R | 1 |
| Chang, E; Cox, T; Fanning, D; Garner, S; Jenkins, DD; Wiest, DB | 1 |
| Barbour, AB; Bentzley, JP; Brown, TR; Buckley, JR; Chang, EY; Hlavacek, AM; Hope, KE; Jenkins, DD; Lowe, DW; Majstoravich, SJ; Martin, RH; Mulvihill, DM; Rollins, LG; Taylor, JJ; Turner, RP; Wiest, DB | 1 |
1 review(s) available for acetylcysteine and Chorioamnionitis
| Article | Year |
|---|---|
Management of clinical chorioamnionitis: an evidence-based approach.
Topics: Acetylcysteine; Adrenal Cortex Hormones; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antioxidants; Antipyretics; Ceftriaxone; Cesarean Section; Chorioamnionitis; Clarithromycin; Clindamycin; Delivery, Obstetric; Endometritis; Evidence-Based Medicine; Female; Gentamicins; Gestational Age; Humans; Magnesium Sulfate; Metronidazole; Practice Guidelines as Topic; Pregnancy; Puerperal Infection; Tocolytic Agents | 2020 |
3 trial(s) available for acetylcysteine and Chorioamnionitis
| Article | Year |
|---|---|
Antenatal N-acetylcysteine to improve outcomes of premature infants with intra-amniotic infection and inflammation (Triple I): randomized clinical trial.
Topics: Acetylcysteine; Adult; Apgar Score; Bronchopulmonary Dysplasia; Chorioamnionitis; Connecticut; Drug Administration Schedule; Female; Gestational Age; Hospital Mortality; Humans; Infant; Infant Mortality; Infant, Premature; Infusions, Intravenous; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Young Adult | 2021 |
Antenatal pharmacokinetics and placental transfer of N-acetylcysteine in chorioamnionitis for fetal neuroprotection.
Topics: Acetylcysteine; Chorioamnionitis; Double-Blind Method; Female; Fetal Blood; Free Radical Scavengers; Humans; Inflammation; Infusions, Intravenous; Male; Maternal-Fetal Exchange; Mothers; Neuroprotective Agents; Pilot Projects; Placenta; Pregnancy; Prospective Studies; Time Factors | 2014 |
Fetal and Neonatal Effects of N-Acetylcysteine When Used for Neuroprotection in Maternal Chorioamnionitis.
Topics: Acetylcysteine; Cerebrovascular Circulation; Chorioamnionitis; Double-Blind Method; Echoencephalography; Electroencephalography; Female; Fetus; Humans; Infant; Infant, Newborn; Magnetic Resonance Imaging; Male; Mothers; Neuroprotective Agents; Pregnancy; Prospective Studies; Ultrasonography, Doppler | 2016 |